Identification of multispecific organic anion transporter 2 expressed predominantly in the liver
about
Molecular identification of a novel carnitine transporter specific to human testis. Insights into the mechanism of carnitine recognitionOATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamiliesTransporters at CNS barrier sites: obstacles or opportunities for drug delivery?Transport mechanism and substrate specificity of human organic anion transporter 2 (hOat2 [SLC22A7]).Blood brain barrier: a challenge for effectual therapy of brain tumorsOchratoxin A: the continuing enigmaMolecular cloning and characterization of a new multispecific organic anion transporter from rat brainDevelopmentally regulated expression of organic ion transporters NKT (OAT1), OCT1, NLT (OAT2), and RoctIdentification and functional assessment of the novel murine organic anion transporter Oat5 (Slc22a19) expressed in kidneyRat organic anion transporter 3 (rOAT3) is responsible for brain-to-blood efflux of homovanillic acid at the abluminal membrane of brain capillary endothelial cellsMolecular and functional analysis of SDCT2, a novel rat sodium-dependent dicarboxylate transporterA novel transporter of SLC22 family specifically transports prostaglandins and co-localizes with 15-hydroxyprostaglandin dehydrogenase in renal proximal tubulesShort-term regulation of organic anion transportersAngiotensin II inhibits activity of human organic anion transporter 3 through activation of protein kinase Calpha: accelerating endocytosis of the transporter.Putative transmembrane domain 12 of the human organic anion transporter hOAT1 determines transporter stability and maturation efficiency.Organic anion and cation transporter expression and function during embryonic kidney development and in organ culture modelsTransport of estrone sulfate by the novel organic anion transporter Oat6 (Slc22a20)Xenobiotic, bile acid, and cholesterol transporters: function and regulation.Structure of renal organic anion and cation transporters.Action of EGF and PGE2 on basolateral organic anion uptake in rabbit proximal renal tubules and hOAT1 expressed in human kidney epithelial cells.A microarray analysis of the temporal response of liver to methylprednisolone: a comparative analysis of two dosing regimens.The organic anion transporter family: from physiology to ontogeny and the clinic.The Role of Dileucine in the Expression and Function of Human Organic Anion Transporter 1 (hOAT1).Mechanisms and clinical implications of renal drug excretion.Immunocytochemistry for amoxicillin and its use for studying uptake of the drug in the intestine, liver, and kidney of rats.Hepatocellular transport proteins and their role in liver disease.Mutational analysis of the role of GXXXG motif in the function of human organic anion transporter 1 (hOAT1).Transmembrane peptide as potent inhibitor of oligomerization and function of human organic anion transporter 1.Structure, function, and regulation of renal organic anion transporters.Evaluation of (99m)technetium-mebrofenin and (99m)technetium-sestamibi as specific probes for hepatic transport protein function in rat and human hepatocytesMolecular mechanism of ochratoxin a transport in the kidney.Molecular and functional identification of organic anion transporter isoforms in cultured bovine mammary epithelial cells (BME-UV).Molecular and cellular physiology of renal organic cation and anion transport.Organic anion transporter 2 transcript variant 1 shows broad ligand selectivity when expressed in multiple cell lines.Identification of transport pathways for citric acid cycle intermediates in the human colon carcinoma cell line, Caco-2.Genetic polymorphisms of drug transporters: pharmacokinetic and pharmacodynamic consequences in pharmacotherapy.Organic anion transporter OAT1 undergoes constitutive and protein kinase C-regulated trafficking through a dynamin- and clathrin-dependent pathwayPolymorphic transporters and platinum pharmacodynamicsRegulation of human organic anion transporter 1 by ANG II: involvement of protein kinase Calpha.Novobiocin is a potent inhibitor for human organic anion transporters.
P2860
Q24300520-2C0095A1-058D-41AD-83DB-917B515E9728Q27001267-3D93E0B3-6815-401F-ADE7-E87F77E99B65Q27690256-B6F0FE0E-7349-416A-B391-47E82EED47FAQ27863334-FC706AA7-ECE8-4CB3-BC39-6840F2A16A02Q28081947-A2EEA7ED-0FD3-40BA-B528-3F83B8A6D6D8Q28237697-76F90D1C-0D30-40BB-BCFA-10B11E3684FBQ28374528-0E1462B1-FC3E-4BAC-8335-313DC1C3F599Q28508498-E6E227F1-F433-48C5-8739-83ADD3A3C82CQ28576093-2E621717-2BB0-4A8C-AE5D-B9A0FEC73821Q28579203-815F8BAE-DA67-4C06-B129-D32A8EAC8D79Q28583210-2CAE18F9-A385-4BDF-A918-B508DB9DB45EQ28593864-D555B98C-EB89-4263-9822-A78E4A968BBDQ33576144-9F8F1D37-E502-4A90-8061-CB91E440E2F1Q33593898-AFDFB148-252A-482F-B96C-AE6CBEA22E16Q33613551-7696F9EC-D37B-407B-B281-9F113CCB2F6CQ33674894-2F681FB3-A9A7-4D0C-8CBF-43C64C9D2015Q33674911-313A594B-9875-4AFF-A9C8-FA44058BD980Q33714593-77911645-9F22-495C-942E-0ECEA82C23ADQ33932614-65B09E8B-A30E-4757-B445-40D14726D3F7Q34279707-CAE2A693-BAE4-409F-863D-5B9D97FB0E7BQ34280803-7FA70AB1-7AFD-4659-A9B6-7DEE5791D4C6Q34310328-A77B4456-AEEF-4C6D-A851-FA6FB52A9731Q34434657-4C903DE5-6E9A-457D-A39F-CAA6204A2EAFQ34479011-26D6F85C-E93F-41CB-A6C4-759709BD8834Q34483537-7A3CE983-865C-4E38-9599-825152EE9C74Q34512014-BE12834F-2AB4-478E-8629-8FDAA82178FAQ34580122-1401CEE7-5343-4E90-8EAB-B88406B25D2CQ34701082-7472AA4C-BEC7-4394-B41C-F3C77326B100Q34944480-317F5B83-FDF0-412F-AA57-C5F5A85B4895Q35086354-C2663CE0-1BEF-4AA7-8698-44FEFDDF8E14Q35155867-AED92A8A-5B0C-4E5E-A9CE-705F06CA5258Q35190748-274768ED-5F3E-4B15-8BB5-EC76773C2E2FQ35842999-D38F725F-3956-4011-ABA2-A29335472C85Q36123428-DA55D71B-D930-4F8A-9938-1C2FC254CAC3Q36572079-F5866CB5-71F4-4529-A6CF-8493A6A98763Q36609738-FE99AFDA-36F9-4570-A1AA-1D02B40F4B0BQ36973667-F5CDE025-6AED-4B51-AC85-9BB4C06C60FAQ36995742-FE993A41-768C-446F-A37E-F1E8AAEBCE27Q37102851-2B3A599A-3447-433B-8058-26B374875BC1Q37196112-97E6F454-29FC-4EFA-AB2F-1030987B66D4
P2860
Identification of multispecific organic anion transporter 2 expressed predominantly in the liver
description
1998 nî lūn-bûn
@nan
1998 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Identification of multispecifi ...... sed predominantly in the liver
@ast
Identification of multispecifi ...... sed predominantly in the liver
@en
Identification of multispecifi ...... sed predominantly in the liver
@en-gb
Identification of multispecifi ...... sed predominantly in the liver
@nl
type
label
Identification of multispecifi ...... sed predominantly in the liver
@ast
Identification of multispecifi ...... sed predominantly in the liver
@en
Identification of multispecifi ...... sed predominantly in the liver
@en-gb
Identification of multispecifi ...... sed predominantly in the liver
@nl
prefLabel
Identification of multispecifi ...... sed predominantly in the liver
@ast
Identification of multispecifi ...... sed predominantly in the liver
@en
Identification of multispecifi ...... sed predominantly in the liver
@en-gb
Identification of multispecifi ...... sed predominantly in the liver
@nl
P2093
P2860
P1433
P1476
Identification of multispecifi ...... sed predominantly in the liver
@en
P2093
N Apiwattanakul
N Nakajima
P2860
P304
P356
10.1016/S0014-5793(98)00585-7
P407
P577
1998-06-12T00:00:00Z